title: Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study.
abstract: BACKGROUND
  Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an autosomal dominant inherited disease with incomplete penetrance and variable expression. Causative mutations in genes encoding 5 desmosomal proteins are found in ≈50% of ARVD/C index patients. Previous genotype-phenotype relation studies involved mainly overt ARVD/C index patients, so follow-up data on relatives are scarce.
  
  
  RESULTS
  One hundred forty-nine ARVD/C index patients (111 male patients; age, 49±13 years) according to 2010 Task Force criteria and 302 relatives from 93 families (282 asymptomatic; 135 male patients; age, 44±13 years) were clinically and genetically characterized. DNA analysis comprised sequencing of plakophilin-2 (PKP2), desmocollin-2, desmoglein-2, desmoplakin, and plakoglobin and multiplex ligation-dependent probe amplification to identify large deletions in PKP2. Pathogenic mutations were found in 87 index patients (58%), mainly truncating PKP2 mutations, including 3 cases with multiple mutations. Multiplex ligation-dependent probe amplification revealed 3 PKP2 exon deletions. ARVD/C was diagnosed in 31% of initially asymptomatic mutation-carrying relatives and 5% of initially asymptomatic relatives of index patients without mutation. Prolonged terminal activation duration was observed more than negative T waves in V(1) to V(3), especially in mutation-carrying relatives <20 years of age. In 45% of screened families, ≥1 affected relatives were identified (90% with mutations).
  
  
  CONCLUSIONS
  Pathogenic desmosomal gene mutations, mainly truncating PKP2 mutations, underlie ARVD/C in the majority (58%) of Dutch index patients and even 90% of familial cases. Additional multiplex ligation-dependent probe amplification analysis contributed to discovering pathogenic mutations underlying ARVD/C. Discovering pathogenic mutations in index patients enables those relatives who have a 6-fold increased risk of ARVD/C diagnosis to be identified. Prolonged terminal activation duration seems to be a first sign of ARVD/C in young asymptomatic relatives.
authors: Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. moniekcox@gmail.com
authors: Moniek G P J
authors: MG
authors: Cox
authors: Paul A
authors: PA
authors: van der Zwaag
authors: Christian
authors: C
authors: van der Werf
authors: Jasper J
authors: JJ
authors: van der Smagt
authors: Maartje
authors: M
authors: Noorman
authors: Zahir A
authors: ZA
authors: Bhuiyan
authors: Ans C P
authors: AC
authors: Wiesfeld
authors: Paul G A
authors: PG
authors: Volders
authors: Irene M
authors: IM
authors: van Langen
authors: Douwe E
authors: DE
authors: Atsma
authors: Dennis
authors: D
authors: Dooijes
authors: Arthur
authors: A
authors: van den Wijngaard
authors: Arjan C
authors: AC
authors: Houweling
authors: Jan D H
authors: JD
authors: Jongbloed
authors: Luc
authors: L
authors: Jordaens
authors: Maarten J
authors: MJ
authors: Cramer
authors: Pieter A
authors: PA
authors: Doevendans
authors: Jacques M T
authors: JM
authors: de Bakker
authors: Arthur A M
authors: AA
authors: Wilde
authors: J Peter
authors: JP
authors: van Tintelen
authors: Richard N W
authors: RN
authors: Hauer